Skip to main content
IMDXSector not reported

Insight Molecular Diagnostics Inc. (IMDX) Insider Trading

In the last 90 days, 3 Insight Molecular Diagnostics Inc. (IMDX) insiders reported 3 open-market purchases totaling $17,999,998 and no sales. The most recent open-market purchase was reported on Nov 17, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$17,999,998
Corporate buyers
3
Latest transaction
Nov 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Nov 17, 2026Broadwood Partners L.P.Corporate insiderOpen Market Purchase3,428,571$1.75$5,999,999
Nov 17, 2026Broadwood Capital IncCorporate insiderOpen Market Purchase3,428,571$1.75$5,999,999
Nov 17, 2026Neal C BradsherCorporate insiderOpen Market Purchase3,428,571$1.75$5,999,999
Apr 27, 2026Broadwood Partners L.P.Corporate insiderOpen Market Purchase570,184$3.56$2,032,250
Apr 27, 2026Broadwood Capital IncCorporate insiderOpen Market Purchase570,184$3.56$2,032,250
Apr 27, 2026Neal C BradsherCorporate insiderOpen Market Purchase570,184$3.56$2,032,250
Apr 20, 2026Broadwood Partners L.P.Corporate insiderOpen Market Purchase182,861$3.57$652,869
Apr 20, 2026Broadwood Capital IncCorporate insiderOpen Market Purchase182,861$3.57$652,869
Apr 20, 2026Neal C BradsherCorporate insiderOpen Market Purchase182,861$3.57$652,869

Common questions

IMDX insider trading FAQ

Are IMDX insiders buying or selling?
Over the last 90 days, IMDX insiders were net buyers, reporting $17,999,998 of open-market purchases and $0.00 of sales.
When was the last IMDX insider purchase?
The most recent open-market purchase of Insight Molecular Diagnostics Inc. stock by an insider was reported on Nov 17, 2026, one of 3 purchases in the last 90 days.
Where does IMDX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Insight Molecular Diagnostics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.